.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Dow
Citi
Cantor Fitzgerald
Farmers Insurance
QuintilesIMS
Federal Trade Commission
UBS
Boehringer Ingelheim
Cipla

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021625

« Back to Dashboard
NDA 021625 describes M.V.I. ADULT, which is a drug marketed by Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the M.V.I. ADULT profile page.

The generic ingredient in M.V.I. ADULT is ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e; vitamin k profile page.

Summary for NDA: 021625

You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'SODIUM','THIAMINE HYDROCHLORIDE','VITAMIN A','VITAMIN E','VITAMIN K') AND hsdb_d' at line 1
Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1